90 related articles for article (PubMed ID: 23623426)
1. The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs.
Freeman CG; Parish CR; Knox KJ; Blackmore JL; Lobov SA; King DW; Senden TJ; Stephens RW
Biomaterials; 2013 Jul; 34(22):5670-6. PubMed ID: 23623426
[TBL] [Abstract][Full Text] [Related]
2. Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx.
Chappell D; Jacob M; Rehm M; Stoeckelhuber M; Welsch U; Conzen P; Becker BF
Biol Chem; 2008 Jan; 389(1):79-82. PubMed ID: 18095872
[TBL] [Abstract][Full Text] [Related]
3. Circulating Heparan Sulfate Fragments Attenuate Histone-Induced Lung Injury Independently of Histone Binding.
Zhang Y; Haeger SM; Yang Y; Dailey KL; Ford JA; Schmidt EP
Shock; 2017 Dec; 48(6):666-673. PubMed ID: 28538085
[TBL] [Abstract][Full Text] [Related]
4. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.
Rehm M; Bruegger D; Christ F; Conzen P; Thiel M; Jacob M; Chappell D; Stoeckelhuber M; Welsch U; Reichart B; Peter K; Becker BF
Circulation; 2007 Oct; 116(17):1896-906. PubMed ID: 17923576
[TBL] [Abstract][Full Text] [Related]
5. Cationised radiolabelled nanoparticles for perfusion imaging of the lungs.
Lobov SA; King DW; Knox KJ; Senden TJ; Stephens RW
Biomaterials; 2013 Feb; 34(6):1732-8. PubMed ID: 23218595
[TBL] [Abstract][Full Text] [Related]
6. The Pulmonary Endothelial Glycocalyx in ARDS: A Critical Role for Heparan Sulfate.
LaRivière WB; Schmidt EP
Curr Top Membr; 2018; 82():33-52. PubMed ID: 30360782
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface.
Constantinescu AA; Vink H; Spaan JA
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1541-7. PubMed ID: 12855481
[TBL] [Abstract][Full Text] [Related]
8. Cationic Polysaccharides Bind to the Endothelial Cell Surface Extracellular Matrix Involving Heparan Sulfate.
Fu L; Bridges CA; Kim HN; Ding C; Bao Hou NC; Yeow J; Fok S; Macmillan A; Sterling JD; Baker SM; Lord MS
Biomacromolecules; 2024 Jun; 25(6):3850-3862. PubMed ID: 38775104
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulphate and hyaluronic acid components of the glycocalyx do not play a role in flow-mediated dilation of the iliac in the anaesthetized pig.
Ruane-O'Hora T; O'Malley D; Buckley MM; Markos F
Can J Physiol Pharmacol; 2019 Aug; 97(8):746-752. PubMed ID: 31084580
[TBL] [Abstract][Full Text] [Related]
10. No need to be HAMLET or BAMLET to interact with histones: binding of monomeric alpha-lactalbumin to histones and basic poly-amino acids.
Permyakov SE; Pershikova IV; Khokhlova TI; Uversky VN; Permyakov EA
Biochemistry; 2004 May; 43(19):5575-82. PubMed ID: 15134431
[TBL] [Abstract][Full Text] [Related]
11. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
12. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels.
Jacob M; Bruegger D; Rehm M; Stoeckelhuber M; Welsch U; Conzen P; Becker BF
Cardiovasc Res; 2007 Feb; 73(3):575-86. PubMed ID: 17196565
[TBL] [Abstract][Full Text] [Related]
13. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
14. Unfractionated Heparin Attenuated Histone-Induced Pulmonary Syndecan-1 Degradation in Mice: a Preliminary Study on the Roles of Heparinase Pathway.
Fu S; Yu S; Zhao Y; Ma X; Li X
Inflammation; 2022 Apr; 45(2):712-724. PubMed ID: 34657233
[TBL] [Abstract][Full Text] [Related]
15. Minimum fragments of the heparin molecule able to produce the accumulation and change of the sulfation pattern of an antithrombotic heparan sulfate from endothelial cells.
Pinhal MA; Santos IA; Silva IF; Dietrich CP; Nader HB
Thromb Haemost; 1995 Oct; 74(4):1169-74. PubMed ID: 8560430
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of heparan sulfates in human lung.
Smits NC; Robbesom AA; Versteeg EM; van de Westerlo EM; Dekhuijzen PN; van Kuppevelt TH
Am J Respir Cell Mol Biol; 2004 Feb; 30(2):166-73. PubMed ID: 12896874
[TBL] [Abstract][Full Text] [Related]
17. Glycocalyx degradation causes microvascular perfusion failure in the ex vivo perfused mouse lung: hydroxyethyl starch 130/0.4 pretreatment attenuates this response.
Strunden MS; Bornscheuer A; Schuster A; Kiefmann R; Goetz AE; Heckel K
Shock; 2012 Nov; 38(5):559-66. PubMed ID: 23042196
[TBL] [Abstract][Full Text] [Related]
18. Degradation of heparan sulfate with heparin lyases.
LeBrun LA; Linhardt RJ
Methods Mol Biol; 2001; 171():353-61. PubMed ID: 11450249
[No Abstract] [Full Text] [Related]
19. Improving impact of heparan sulfate on the endothelial glycocalyx abnormalities in atherosclerosis as revealed by glycan-protein interactome.
Chen Q; Xu X; Xie S; Sheng A; Han N; Tian Z; Wang X; Li F; Linhardt RJ; Zhang F; Jin L; Zhang Q; Chi L
Carbohydr Polym; 2024 Apr; 330():121834. PubMed ID: 38368111
[TBL] [Abstract][Full Text] [Related]
20. Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen.
Horner AA
Biochem J; 1990 Mar; 266(2):553-9. PubMed ID: 2138457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
